Loading
A phase 2 trial of Laser interstitial thermal therapy systems in Prostate cancer, run by National Cancer Institute (NCI), completed.
MR Image Guided Therapy in Prostate Cancer is a phase 2 interventional study registered as NCT01377753 by National Cancer Institute (NCI), with 15 participants recorded, started 2011-08-12 and reaching its primary completion in 2017-01-01. Interventions recorded: Visualase Thermal Therapy System. Conditions recorded: Prostate Cancer, Prostatic Neoplasms.
Linked to the technology Laser interstitial thermal therapy systems because the registry names it ("visualase") among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Laser interstitial thermal therapy systems (NeuroBlate, Visualase) and the tag pipeline.
Shares Laser interstitial thermal therapy systems (NeuroBlate, Visualase) and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/